发明名称 Imaging probes, methods of making imaging probes, and methods of imaging
摘要 In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, embodiments of the present disclosure, in one aspect, relate to methods of detecting the over-expression of epidermal growth factor receptor (EGFR) in a subject or sample, methods of diagnosing the presence of one or more angiogenesis related diseases or related biological events in a subject or sample, method of monitoring the progress of one or more angiogenesis related diseases or related biological events in a subject or sample, a 18F-FBEM-CYS-ZEGFR:1907 probe, compositions including a 18F-FBEM-CYS-ZEGFR:1907 probe, and pharmaceutical compositions including a 18F-FBEM-CYS-ZEGFR:1907 probe and the like.
申请公布号 US8753605(B2) 申请公布日期 2014.06.17
申请号 US201113199428 申请日期 2011.08.30
申请人 The Board of Trustees of the Leland Stanford Junior University 发明人 Cheng Zhen;Gambhir Sanjiv Sam;Miao Zheng;Liu Hongguang;Ren Gang
分类号 A61K51/00;A61M36/14;A61K49/00;A61K38/16;A61K49/14;A61K51/08 主分类号 A61K51/00
代理机构 Thomas|Horstemeyer, LLP 代理人 Thomas|Horstemeyer, LLP
主权项 1. A method of detecting the over-expression of epidermal growth factor receptor (EGFR) in a subject, comprising: administering to the subject a 18F-FBEM-CYS-ZEGFR:1907 probe, wherein 18F-FBEM is N-2-(4-18F-fluorobenzamido)ethyl-maleimide), wherein ZEGFR:1907 is SEQ ID NO: 1, and CYS is cysteine; imaging at least a portion of the subject; and detecting the 18F-FBEM-CYS-ZEGFR:1907 probe, wherein the location of the 18F-FBEM-CYS-ZEGFR:1907 probe corresponds to the over-expression of the EGFR.
地址 Palo Alto CA US
您可能感兴趣的专利